Skip to main content

Advertisement

SpringerLink
Log in

Endoscopic Interventions in the Treatment of Obesity and Diabetes

  • Mentored Reviews
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Obesity is a global health problem which is on the rise and is strongly associated with the development of type 2 diabetes and other comorbidities. Bariatric surgery is now an established treatment for both these conditions, leading to impressive results in weight loss and glycemic control. More recently, we have seen the development of various endoscopic devices as potential alternatives or adjuncts to bariatric surgery. In this state-of-the-art review, we outline the current landscape of endoscopic treatments available for the management of both obesity and diabetes, including the clinical evidence supporting their use, efficacy, safety, and potential mechanisms of action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Adapted from Ashrafian et al. [61]

Similar content being viewed by others

References

  1. WHO. Obesity and overweight. Factsheet No. 31; 2015.

  2. The Organisation for Economic Co-operation and Development. Obesity update; 2017.

  3. International Diabetes Federation, Atlas, 7th ed. 2015.

  4. Buchwald H, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–256.

    Article  PubMed  Google Scholar 

  5. Ashrafian H, et al. Effects of bariatric surgery on cardiovascular function. Circulation. 2008;118:2091–2102.

    Article  PubMed  Google Scholar 

  6. Ashrafian H, et al. Bariatric surgery or non-surgical weight loss for obstructive sleep apnoea? A systematic review and comparison of meta-analyses. Obes Surg. 2015;25:1239–1250.

    Article  PubMed  Google Scholar 

  7. Cohen RV, et al. The Diabetes Surgery Summit II guidelines: a disease-based clinical recommendation. Obes Surg. 2016;26:1989–1991.

    Article  PubMed  Google Scholar 

  8. Schauer PR, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017;376:641–651.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Muller-Stich BP, et al. Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis. Ann Surg. 2015;261:421–429.

    Article  PubMed  Google Scholar 

  10. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335–342.

    Article  PubMed  CAS  Google Scholar 

  11. Nathan H, et al. Strategies for reducing population surgical costs in medicare: local referrals to low-cost hospitals. Ann Surg. 2018;267:878–885.

    Article  PubMed  Google Scholar 

  12. Kim SH, et al. Current status of intragastric balloon for obesity treatment. World J Gastroenterol. 2016;22:5495–5504.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Nunes GC, et al. Assessment of weight loss with the intragastric balloon in patients with different degrees of obesity. Surg Laparosc Endosc Percutan Tech. 2017;27:e83–e86.

    Article  PubMed  Google Scholar 

  14. Imaz I, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18:841–846.

    Article  PubMed  Google Scholar 

  15. Brooks J, Srivastava ED, Mathus-Vliegen EM. One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K. Obes Surg. 2014;24:813–819.

    Article  PubMed  CAS  Google Scholar 

  16. Ponce J, Quebbemann BB, Patterson EJ. Prospective, randomized, multicenter study evaluating safety and efficacy of intragastric dual-balloon in obesity. Surg Obes Relat Dis. 2013;9:290–295.

    Article  PubMed  Google Scholar 

  17. Machytka E, et al. Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study. Endoscopy. 2017;49:154–160.

    PubMed  Google Scholar 

  18. Mion F, et al. Swallowable Obalon(R) gastric balloons as an aid for weight loss: a pilot feasibility study. Obes Surg. 2013;23:730–733.

    Article  PubMed  Google Scholar 

  19. Trande P, et al. Efficacy, tolerance and safety of new intragastric air-filled balloon (Heliosphere BAG) for obesity: the experience of 17 cases. Obes Surg. 2010;20:1227–1230.

    Article  PubMed  Google Scholar 

  20. Gaggiotti G, et al. Adjustable totally implantable intragastric prosthesis (ATIIP)-Endogast for treatment of morbid obesity: one-year follow-up of a multicenter prospective clinical survey. Obes Surg. 2007;17:949–956.

    Article  PubMed  Google Scholar 

  21. FDA. Obesity treatment devices. https://www.fda.gov/medicaldevices/productsandmedicalprocedures/obesitydevices/default.htm; 2017. Accessed May 10, 2018.

  22. Giardiello C, et al. Air-filled vs water-filled intragastric balloon: a prospective randomized study. Obes Surg. 2012;22:1916–1919.

    Article  PubMed  Google Scholar 

  23. Bernante P, et al. Green urine after intragastric balloon placement for the treatment of morbid obesity. Obes Surg. 2003;13:951–953.

    Article  PubMed  Google Scholar 

  24. Galloro G, et al. New technique for endoscopic removal of intragastric balloon placed for treatment of morbid obesity. Obes Surg. 2007;17:658–662.

    Article  PubMed  Google Scholar 

  25. Abu Dayyeh BK, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82:425–438.

    Article  PubMed  Google Scholar 

  26. Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18:1611–1617.

    Article  PubMed  Google Scholar 

  27. FDA. The FDA alerts health care providers about potential risks with liquid-filled intragastric balloons. https://www.fda.gov/medicaldevices/resourcesforyou/healthcareproviders/ucm540655.htm; 2017. Accessed May 10, 2018.

  28. Gaur S, et al. Balancing risk and reward: a critical review of the intragastric balloon for weight loss. Gastrointest Endosc. 2015;81:1330–1336.

    Article  PubMed  Google Scholar 

  29. Kotzampassi K, et al. 500 intragastric balloons: what happens 5 years thereafter? Obes Surg. 2012;22:896–903.

    Article  PubMed  Google Scholar 

  30. Mathus-Vliegen EMH, Tytgat GNJ. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc. 2005;61:19–27.

    Article  PubMed  Google Scholar 

  31. Machytka E, et al. Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obes Surg. 2011;21:1499–1507.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Popov VB, et al. The impact of intragastric balloons on obesity-related co-morbidities: a systematic review and meta-analysis. Am J Gastroenterol. 2017;112:429–439.

    Article  PubMed  Google Scholar 

  33. Chan AO, et al. The effect of intragastric balloon placement on weight loss and type 2 diabetes control. Aliment Pharmacol Ther. 2008;28:162–164. (author reply 164-5).

    Article  PubMed  CAS  Google Scholar 

  34. Crea N, et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg. 2009;19:1084–1088.

    Article  PubMed  Google Scholar 

  35. Su HJ, et al. Effect of intragastric balloon on gastric emptying time in humans for weight control. Clin Nucl Med. 2013;38:863–868.

    Article  PubMed  Google Scholar 

  36. Gomez V, Woodman G, Abu BK. Dayyeh, Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: results of a prospective study. Obesity (Silver Spring). 2016;24:1849–1853.

    Article  Google Scholar 

  37. Ladabaum U, et al. Differential symptomatic and electrogastrographic effects of distal and proximal human gastric distension. Am J Physiol. 1998;275:G418–G424.

    PubMed  CAS  Google Scholar 

  38. Mathus-Vliegen EM, de Groot GH. Fasting and meal-induced CCK and PP secretion following intragastric balloon treatment for obesity. Obes Surg. 2013;23:622–633.

    Article  PubMed  Google Scholar 

  39. Feinle C, et al. Effects of duodenal fat, protein or mixed-nutrient infusions on epigastric sensations during sustained gastric distension in healthy humans. Neurogastroenterol Motil. 2002;14:205–213.

    Article  PubMed  CAS  Google Scholar 

  40. Konopko-Zubrzycka M, et al. The effect of intragastric balloon on plasma ghrelin, leptin, and adiponectin levels in patients with morbid obesity. J Clin Endocrinol Metab. 2009;94:1644–1649.

    Article  PubMed  CAS  Google Scholar 

  41. Fuller NR, et al. An intragastric balloon produces large weight losses in the absence of a change in ghrelin or peptide YY. Clin Obes. 2013;3:172–179.

    Article  PubMed  CAS  Google Scholar 

  42. Sullivan S, et al. Aspiration therapy leads to weight loss in obese subjects: a pilot study. Gastroenterology. 2013;145:1245–1252.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Forssell H, Noren E. A novel endoscopic weight loss therapy using gastric aspiration: results after 6 months. Endoscopy. 2015;47:68–71.

    Article  PubMed  Google Scholar 

  44. Thompson CC, et al. Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial. Am J Gastroenterol. 2017;112:447–457.

    Article  PubMed  Google Scholar 

  45. James AN, Ryan JP, Parkman HP. Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle. Am J Physiol Gastrointest Liver Physiol. 2003;285:G291–G297.

    Article  PubMed  CAS  Google Scholar 

  46. Foschi D, et al. Effects of intramural administration of Botulinum Toxin A on gastric emptying and eating capacity in obese patients. Dig Liver Dis. 2008;40:667–672.

    Article  PubMed  CAS  Google Scholar 

  47. Garcia-Compean D, Maldonado Garza H. Intragastric injection of botulinum toxin for the treatment of obesity. Where are we? World J Gastroenterol. 2008;14:1805–1809.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  48. Bang CS, et al. Effect of intragastric injection of botulinum toxin A for the treatment of obesity: a meta-analysis and meta-regression. Gastroenterology. 2015;148:670.

    Article  Google Scholar 

  49. Fogel R, et al. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc. 2008;68:51–58.

    Article  PubMed  Google Scholar 

  50. Kumar N, Thompson CC. Transoral outlet reduction for weight regain after gastric bypass: long-term follow-up. Gastrointest Endosc. 2016;83:776–779.

    Article  PubMed  Google Scholar 

  51. Brethauer SA, et al. Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of TRIM trial. Surg Obes Relat Dis. 2012;8:296–303.

    Article  PubMed  Google Scholar 

  52. Familiari P, et al. Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome. Gastrointest Endosc. 2011;74:1248–1258.

    Article  PubMed  Google Scholar 

  53. Sharaiha RZ, et al. Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population. Endoscopy. 2015;47:164–166.

    PubMed  Google Scholar 

  54. Abu Dayyeh BK, et al. Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol. 2017;15:37–43.

    Article  PubMed  Google Scholar 

  55. van Wezenbeek MR, et al. Long-term results of primary vertical banded gastroplasty. Obes Surg. 2015;25:1425–1430.

    Article  PubMed  Google Scholar 

  56. Colquitt JL, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8:Cd003641.

    Google Scholar 

  57. Lopez-Nava G, et al. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up. Obes Surg. 2017;27:2649–2655.

    Article  PubMed  Google Scholar 

  58. Sullivan S, et al. 100 12 month randomized sham controlled trial evaluating the safety and efficacy of targeted use of endoscopic suture anchors for primary obesity: the ESSENTIAL study. Gastroenterology. 2016;150:S25–S26.

    Article  Google Scholar 

  59. Espinos JC, et al. Gastrointestinal physiological changes and their relationship to weight loss following the POSE procedure. Obes Surg. 2016;26:1081–1089.

    Article  PubMed  CAS  Google Scholar 

  60. Marinos G, et al. Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study. Surg Obes Relat Dis. 2014;10:929–934.

    Article  PubMed  Google Scholar 

  61. Ashrafian H, et al. Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass. Obes Rev. 2011;12:e257–e272.

    Article  PubMed  CAS  Google Scholar 

  62. Sandler BJ, et al. Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve. Surg Endosc. 2011;25:3028–3033.

    Article  PubMed  Google Scholar 

  63. Sandler BJ, et al. One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity. Surg Endosc. 2015;29:3298–3303.

    Article  PubMed  Google Scholar 

  64. Garvey WT. Ablation of the duodenal mucosa as a strategy for glycemic control in type 2 diabetes: role of nutrient signaling or simple weight loss. Diabetes Care. 2016;39:2108–2110.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Cherrington AD, et al. Hydrothermal duodenal mucosal resurfacing: role in the treatment of metabolic disease. Gastrointest Endosc Clin N Am. 2017;27:299–311.

    Article  PubMed  Google Scholar 

  66. Ashrafian H, et al. Metabolic surgery and cancer: protective effects of bariatric procedures. Cancer. 2011;117:1788–1799.

    Article  PubMed  Google Scholar 

  67. Rajagopalan H, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study. Diabetes Care. 2016;39:2254–2261.

    Article  PubMed  CAS  Google Scholar 

  68. Theodorakis MJ, et al. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am J Physiol Endocrinol Metab. 2006;290:E550–E559.

    Article  PubMed  CAS  Google Scholar 

  69. Salinari S, et al. Nutrient infusion bypassing duodenum–jejunum improves insulin sensitivity in glucose-tolerant and diabetic obese subjects. Am J Physiol Endocrinol Metab. 2013;305:E59–E66.

    Article  PubMed  CAS  Google Scholar 

  70. Betzel B, et al. Weight reduction and improvement in diabetes by the duodenal–jejunal bypass liner: a 198 patient cohort study. Surg Endosc. 2017;31:2881–2891.

    Article  PubMed  Google Scholar 

  71. de Jonge C, et al. Endoscopic duodenal–jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg. 2013;23:1354–1360.

    Article  PubMed  Google Scholar 

  72. de Moura EG, et al. Effects of duodenal–jejunal bypass liner (EndoBarrier(R)) on gastric emptying in obese and type 2 diabetic patients. Obes Surg. 2015;25:1618–1625.

    Article  PubMed  Google Scholar 

  73. Sauer N, et al. A new endoscopically implantable device (SatiSphere) for treatment of obesity–efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels. Obes Surg. 2013;23:1727–1733.

    Article  PubMed  Google Scholar 

  74. Machytka E, et al. Sa1596 endoscopically-placed, Satisphere; duodenal insert for treatment of obesity—pilot trial with second generation device. Gastrointest Endosc. 2014;79:268.

    Article  Google Scholar 

  75. Machytka E, et al. Partial jejunal diversion using an incisionless magnetic anastomosis system: 1-year interim results in patients with obesity and diabetes. Gastrointest Endosc. 2017;86:904–912.

    Article  PubMed  Google Scholar 

  76. Welbourn R, et al. First registry report to March 2010: Henly-on-Thames: the United Kingdom National Bariatric Surgery Registry. Oxfordshire: Dendritic Clinical Systems; 2011.

    Google Scholar 

  77. Chang SH, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149:275–287.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Monkhouse SJ, Morgan JD, Norton SA. Complications of bariatric surgery: presentation and emergency management—a review. Ann R Coll Surg Engl. 2009;91:280–286.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery & Cancer, Imperial College London, London, UK

    A. Ruban, H. Ashrafian & J. P. Teare

  2. University College Hospital, London, UK

    A. Uthayakumar

Authors
  1. A. Ruban
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Uthayakumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Ashrafian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. P. Teare
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Ruban.

Ethics declarations

Conflict of interest

A. Ruban and J. P. Teare received travel fees support and funding for research from GI Dynamics, Inc. A. Uthayakumar and H. Ashrafian report no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruban, A., Uthayakumar, A., Ashrafian, H. et al. Endoscopic Interventions in the Treatment of Obesity and Diabetes. Dig Dis Sci 63, 1694–1705 (2018). https://doi.org/10.1007/s10620-018-5117-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-018-5117-1

Keywords

Search

Navigation